Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 29% ± 11% | |
endothelial cell | 4 studies | 21% ± 5% | |
ciliated cell | 4 studies | 24% ± 5% | |
plasmacytoid dendritic cell | 3 studies | 19% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 16% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1538.57 | 2642 / 2642 | 100% | 68.87 | 704 / 705 |
breast | 100% | 2003.91 | 459 / 459 | 100% | 26.09 | 1115 / 1118 |
esophagus | 100% | 1576.20 | 1445 / 1445 | 99% | 12.98 | 182 / 183 |
kidney | 100% | 1864.17 | 89 / 89 | 99% | 28.80 | 896 / 901 |
prostate | 100% | 2019.02 | 245 / 245 | 99% | 27.80 | 499 / 502 |
lung | 100% | 1948.49 | 578 / 578 | 99% | 23.45 | 1148 / 1155 |
thymus | 100% | 2730.30 | 653 / 653 | 99% | 34.79 | 601 / 605 |
ovary | 100% | 2119.81 | 180 / 180 | 99% | 20.25 | 427 / 430 |
bladder | 100% | 1780.71 | 21 / 21 | 99% | 19.46 | 500 / 504 |
pancreas | 100% | 1203.22 | 327 / 328 | 99% | 25.03 | 177 / 178 |
intestine | 100% | 1695.47 | 966 / 966 | 99% | 19.93 | 522 / 527 |
skin | 100% | 1507.09 | 1808 / 1809 | 99% | 23.35 | 466 / 472 |
uterus | 100% | 2258.99 | 170 / 170 | 98% | 14.13 | 451 / 459 |
stomach | 100% | 1509.61 | 359 / 359 | 98% | 16.79 | 280 / 286 |
adrenal gland | 100% | 2490.33 | 258 / 258 | 98% | 26.01 | 225 / 230 |
liver | 100% | 898.08 | 226 / 226 | 95% | 15.10 | 385 / 406 |
adipose | 100% | 1908.09 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2072.10 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 15.70 | 29 / 29 |
spleen | 100% | 1812.98 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.90 | 1 / 1 |
muscle | 100% | 969.88 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1432.48 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 23.28 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 98% | 11.57 | 44 / 45 |
peripheral blood | 91% | 892.32 | 841 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | TSPAN31 |
Protein name | Tetraspanin 31 Tetraspanin 31, isoform CRA_a (cDNA FLJ55837, highly similar to Tetraspanin-31) Tetraspanin-31 (Tspan-31) (Sarcoma-amplified sequence) |
Synonyms | SAS hCG_40149 |
Description | |
Accessions | ENST00000547472.5 B4DFJ7 ENST00000553089.5 ENST00000552816.5 F8VW54 ENST00000549052.5 F8VP43 Q12999 F8VWE0 ENST00000547992.5 F8VVF8 ENST00000257910.8 ENST00000548167.1 F8VS78 F8VNT7 |